Here's what's coming up this week on Contemporary OB/GYN®.
Long COVID remains a mystery, more than a year after the condition first arose. To find answers, the National Institutes of Health (NIH) has created a research initiative, awarding grants totaling roughly $470 million.
The Vaccines and Related Biological Products Advisory Committee has yet to vote on whether to recommend the extra shots.
We spoke with Hadine Joffe, MD, MSc about what to expect from this year's North American Menopause Society's (NAMS) Annual Meeting.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More